| Prev Close: | 17.89 |
|---|---|
| Open: | 17.82 |
| Bid: | 6.76 x 100 |
| Ask: | N/A |
| 1y Target Est: | 19.71 |
| Beta: | 1.47 |
| Next Earnings Date: | 5-Aug-13 |
| Day's Range: | 17.41 - 17.90 |
|---|---|
| 52wk Range: | 12.62 - 19.89 |
| Volume: | 33,632 |
| Avg Vol (3m): | 59,113 |
| Market Cap: | 499.50M |
| P/E (ttm): | 377.66 |
| EPS (ttm): | 0.05 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- China Biotech In Review: Sagent Buys Out China JV Partner For $25 Millionat Seeking Alpha(Sun May 12)
- SAGENT PHARMACEUTICALS, INC. FinancialsEDGAR Online Financials(Sat May 11)
- Q1 2013 SAGENT Pharmaceuticals Inc Earnings Release - Before Market OpenCCBN(Mon May 6)
- Sagent Pharmaceuticals Reports First Quarter 2013 Financial ResultsGlobeNewswire(Mon May 6)
- Sagent Pharmaceuticals Announces Agreement to Acquire Remaining 50% Interest in Chinese Manufacturing Joint VentureGlobeNewswire(Mon May 6)
- SAGENT PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations anEDGAR Online(Mon May 6)
- Wall Street Transcript Interview with David Amsellem, Managing Director and Senior Research Analyst at Piper Jaffray & Co.: Alternative Dosage Forms Create Barriers Against Competition in GenericsWall Street Transcript(Thu May 2)
- Sagent Pharmaceuticals Sets Date and Time for Release of First Quarter 2013 Financial ResultsGlobeNewswire(Wed Apr 24)
- 3 Biggest Biotech Crashes This Monthat Motley Fool(Sun Mar 31)
- Follow The Crashing Biotechs: 4 Stocks Fresh From A Fallat Seeking Alpha(Wed Mar 20)
- SAGENT PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial SEDGAR Online(Tue Mar 19)
- Sagent Pharmaceuticals Appoints James M. Hussey as PresidentGlobeNewswire(Tue Mar 19)
- SAGENT PHARMACEUTICALS, INC. Files SEC form 10-K, Annual ReportEDGAR Online(Mon Mar 18)
- This Week in Biotechat Motley Fool(Sat Mar 16)
- Picking Up the Pieces of Shattered Spectrumat Motley Fool(Thu Mar 14)
Press Releases
- Sagent Pharmaceuticals Reports First Quarter 2013 Financial ResultsGlobeNewswire(Mon May 6)
- Sagent Pharmaceuticals Announces Agreement to Acquire Remaining 50% Interest in Chinese Manufacturing Joint VentureGlobeNewswire(Mon May 6)
- Sagent Pharmaceuticals Sets Date and Time for Release of First Quarter 2013 Financial ResultsGlobeNewswire(Wed Apr 24)
Must Read
- News Corp. board approves poison pill, $500 million stock buyback before splitThe Canadian Press(Fri May 24)
- National Bank considering new acquisitions in Canadian wealth managementThe Canadian Press(Fri May 24)
- MTS to sell Allstream to Egyptian investment group, focus on Manitoba marketThe Canadian Press(Fri May 24)
- Loonie lower despite positive durable goods data, little else on calendarThe Canadian Press(Fri May 24)
- Valeant deal sparks share jump, helps TSX ends week higherReuters(Fri May 24)